GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...
North America Leads in Revenue Share with Robust Immunization Infrastructure while Asia-Pacific Drives Fastest Growth Fueled ...
Report with market evolution powered by AI - The global gastroparesis drugs market size is estimated to grow by USD 1.42 ...
London open The FTSE 100 is expected to open 14 points higher on Wednesday, having closed down 0.4% on Tuesday at 8,258.61.
Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...
Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...
Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...
London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License ...
Worldline, Alstom, Teleperformance... ont connu des chutes boursières inédites, conséquence de la financiarisation de ...
Zacks.com on MSN16h
FDA Accepts GSK's BLA for Blenrep Combos in Multiple MyelomaGSK plc GSK announced that the FDA accepted its biologics license application (BLA) seeking approval for the Blenrep ...
Report Ocean has published a new report on the Sleep Disorder Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback